Literature DB >> 18704290

Use of mammography and Pap smear in Estonia, a country without organized cancer screening.

Mare Tekkel1, Tatjana Veideman, Aleksei Baburin, Mati Rahu.   

Abstract

OBJECTIVES: To analyze mammography and Pap smear status in Estonia where no organized population-based cancer screening is available.
METHODS: 5000 individuals (aged 16-64) were randomly chosen from the national population register; among them, 1755 women filled out postal questionnaires.
RESULTS: 50% of respondents aged 45-64 reported having taken a mammogram, 51% of women aged 25-64 had the Pap smear at least once in their lifetime. Corresponding figures for the past two years were 37% and 30%. Irrespective of age, women taking fewer tests over the past two years were rural workers, unemployed, and health behavior recommendations ignorers. In most cases, initiative for mammogram came from women, and from the physician in the case of Pap smear. Moderate increase in mammography use occurred after a project for early detection of breast cancer was launched.
CONCLUSION: Women must continuously be informed that early detection of breast and cervical cancer is possible. Young women should be encouraged to ask for Pap testing. Knowledge of family physicians should be improved.

Entities:  

Mesh:

Year:  2007        PMID: 18704290     DOI: 10.1007/s00038-007-6015-z

Source DB:  PubMed          Journal:  Int J Public Health        ISSN: 1661-8556            Impact factor:   3.380


  2 in total

1.  Determinants of delay in diagnosis and end stage at presentation among breast cancer patients in Iran: a multi-center study.

Authors:  Elahe Foroozani; Reza Ghiasvand; Mohammad Mohammadianpanah; Sima Afrashteh; Dariush Bastam; Fatemeh Kashefi; Saba Shakarami; Mostafa Dianatinasab
Journal:  Sci Rep       Date:  2020-12-08       Impact factor: 4.379

2.  Identifying women at risk for delayed presentation of breast cancer: a cross-sectional study in Estonia.

Authors:  Kaire Innos; Peeter Padrik; Vahur Valvere; Evelyn Eelma; Riina Kütner; Jaak Lehtsaar; Mare Tekkel
Journal:  BMC Public Health       Date:  2013-10-09       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.